Speckle-Type POZ Protein Down-Regulates Matrix Metalloproteinase 2 Expression via Sp1/PI3K/Akt Signaling Pathway in Colorectal Cancer
Authors:
- 19 December 2017
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 63 (2) , 395-402
Abstract
Elevated expression of matrix metalloproteinases (MMPs) is correlated with invasion and metastasis of colorectal cancer (CRC). Recently, a previous study has suggested that speckle-type POZ protein (SPOP) could inhibit cancer cell proliferation and migration through down-regulation of MMP2 and MMP7, with a mechanism remaining unknown.Keywords
Funding Information
- Jiangxi Provincial Department of Science and Technology (20142BAB215037, 20171BAB205060)
- Foundation of Jiangxi Provincial Health Department (20175474)
This publication has 30 references indexed in Scilit:
- Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genesNature Genetics, 2012
- Herpes Simplex Virus Type 2 Infection of Human Epithelial Cells Induces CXCL9 Expression and CD4+ T Cell Migration via Activation of p38-CCAAT/Enhancer-Binding Protein-β PathwayThe Journal of Immunology, 2012
- Diverse somatic mutation patterns and pathway alterations in human cancersNature, 2010
- Antimetastatic potential of fisetin involves inactivation of the PI3K/Akt and JNK signaling pathways with downregulation of MMP-2/9 expressions in prostate cancer PC-3 cellsMolecular and Cellular Biochemistry, 2009
- Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-κB/Sp1-mediated signaling pathwaysCarcinogenesis, 2009
- Nerve Growth Factor Induces Endothelial Cell Invasion and Cord Formation by Promoting Matrix Metalloproteinase-2 Expression through the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway and AP-2 Transcription FactorJournal of Biological Chemistry, 2007
- Matrix Metalloproteinase Inhibitors and Cancer—Trials and TribulationsScience, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Matrix metalloproteinase–1 is associated with poor prognosis in colorectal cancerNature Medicine, 1996
- Matrix metalloproteinase–1 is associated with poor prognosis in colorectal cancerNature Medicine, 1996